Informations:
Erreur:
ID
12464
Description
The purpose of this study is to test the hypothesis that the onset of the antiplatelet effect of ticagrelor is more rapid and greater than clopidogrel in Chinese patients with ACS. https://clinicaltrials.gov/ct2/show/NCT01864005
Lien
https://clinicaltrials.gov/ct2/show/NCT01864005
Mots-clés
Versions (2)
- 28/07/2015 28/07/2015 -
- 21/11/2015 21/11/2015 -
Téléchargé le
21 novembre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility HouYi Acute Coronary Syndrome NCT01864005
Similar models
Eligibility criteria
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Informed consent
Item
Provision of informed consent prior to any study specific procedures
boolean
C0021430 (UMLS CUI-1)
Gender
Item
Female or male
boolean
C0079399 (UMLS CUI-1)
Age
Item
Aged at least 18 years
boolean
C0001779 (UMLS CUI-1)
Pregnancy
Item
Females of child-bearing potential must have a negative urine pregnancy test at enrolment
boolean
C0549206 (UMLS CUI-1)
Contraceptive
Item
Females of child-bearing potential must be willing to use reliable contraception
boolean
C0009871 (UMLS CUI-1)
Acute coronary syndrome
Item
Index event of non-ST or ST segment elevation ACS.
boolean
C0948089 (UMLS CUI [1])
Clopidogrel contraindicated
Item
Contraindication or other reason that clopidogrel should not be administered
boolean
C1319916 (UMLS CUI-1)
Ticagrelor contraindicated
Item
Contraindication or other reason that ticagrelor should not be administered
boolean
C1999375 (UMLS CUI-1)
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)
Oral anticoagulants
Item
Oral anticoagulation therapy within 30 days prior to randomisation or cannot be stopped
boolean
C0354604 (UMLS CUI-1)
GPIIb/IIIa receptor antagonist
Item
GP IIb/IIIa receptor antagonists therapy within 30 days prior to randomisation or cannot be stopped
boolean
C3640054 (UMLS CUI-1)
Ticagrelor
Item
Ticagrelor within 14 days prior to randomisation
boolean
C1999375 (UMLS CUI-1)
Clopidogrel
Item
Clopidogrel within 14 days prior to randomisation
boolean
C0070166 (UMLS CUI-1)
Thienopyridines
Item
P2Y12 inhibitors within 14 days prior to randomisation
boolean
C2936588 (UMLS CUI-1)
Hemodialysis
Item
Requires dialysis
boolean
C0019004 (UMLS CUI-1)
NSAID
Item
Nonselective non-steroidal anti-inflammatory drugs therapy that cannot be stopped
boolean
C0003211 (UMLS CUI-1)
Prostacycline
Item
prostacyclins (PGI2) therapy that cannot be stopped
boolean
C2825061 (UMLS CUI-1)